Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
- Type
- Correction
- Notice date
- 8/17/2017 0:00
- Journal
- NEJM: The New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Notice DOI
- 10.1056/nejmx170011
- Original paper DOI
- 10.1056/nejmoa1703643